Maitreya Medicare Limited is an India-based company, which operates approximately 125 bedded, multispecialty hospitals. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary and tertiary care. It offers a comprehensive range of healthcare services and super specialties, including cardiology, urology, oncology, laparoscopic surgery, neurology, neurosurgery, spine surgery, nephrology, including dialysis, gastroenterology, gastrointestinal surgery, cardiothoracic surgery, oncosurgery, orthopedic surgery, including joint replacements and arthroscopic surgeries, gynecology and high-risk obstetrics, hepatocellular billary surgery, and critical care medicine, among others. The Company's facility consists of a Cath lab with Ivus/FFR/Rota and an approximately 20-bed Intensive Care Unit (ICU) fully equipped with ECMO/CRRT ventilators and monitors. Its subsidiaries include Maitreya Hospital Private Limited and Maitreya Lifescience Private Limited.As of 25 May 2026, Maitreya share price is ₹165.00. The stock opened at ₹160.00, compared to its previous close of ₹167.60. During today's trading session, Maitreya share price moved in the range of ₹158.05 to ₹171.55, with an average price of ₹164.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹158.05 and a high of ₹171.55. On the performance front, Maitreya share price has declined by 33.20% over the last six months and is down 41.81% on a year-on-year basis.
The market capitalization of Maitreya is ₹114 Crs, with a P/E ratio of 110.7 and a dividend yield of 0.00%.